Usually only a missionary position is used to do sex and that also at the same place, that’s our bedroom, which is making sex a boring activity. This is leading to the uninteresting sex life that is finally affecting the relationship with your partner. It has now become a necessity to break the monotonous routine of sex and to try out the new things to rejuvenate the sex life. Here are some tips that will help you to make your sex life more thrilling and break the monotonous sex routine.
Make Sex Passionate
Usually the passion in the sex gets sidelined over time and sex merely remains a mechanical activity for both the partners. Thus, to rejuvenate the sex life the first thing you could do is to make sex passionate. The only thing you need to do is to reignite the fire of passion again to make it the most exciting act that you both could enjoy. While engaging in the sex, foreplay can be brought in the picture. Foreplay can be done either by giving a special sensual message all over the body, or even by the oral sex. Please try out the things that you are comfortable with. Undressing each other slowly and steadily may also be done as the foreplay. Another thing is to tease each other during the sex that would surely create a new sexual zing. Give a special consideration towards the likes and dislikes of your partner. Concentrating on the likes will surely get your partner is best of his mood for sex.
Try New Things
Yes, to break the monotonous sex routine, you need to try out the new things that will revitalize your sex life. New things is to not to try something incredible but to do the things as if you are just newly married couple and trying if for the first time. The best thing you could do is to try out the different sex positions instead of regular missionary position to break the boredom. You could try women on top position, sideways position, cowgirl position, etc. to make sex more thrilling experience for both the partners. You can even fit a mirror in the bedroom in front of you bed and you may watch each other while doing sex. This could really turn both of you on, which will finally lead to most ecstatic experience of your life. The new things you could try by playing the card games together, whoever loses has to remove the clothes. This will create a stepwise sexual ecstasy that will create the most exotic feeling and surely both of you will love it. You can even have the bath together in a one bathtub, washing each other bodies will explore you the new erogenous zones of your partner that will make you ready for the best sexual ride of your life.
Sex at Different Places
Sex is the best when tried out everywhere. The sex at different places has the different levels of excitement that will surely be helpful in breaking the monotonous routine sex. Sex on beach is one of the most passionate sex places, which is loved by both the partners. Having sex on the sand below the sun really turns out to be most passionate sexual experience of the life. Sex done even at different places in hours like on dinner table in the kitchen, bathroom, living room on the sofa are found to rekindle the sexual zing in both the partners. Sex can even tried in the garden, in the swimming pool or even next to the pool while drying. This type of the sexual experience will surely break the monotonous sexual routine and you will once again find sex as the most pleasurable and enjoyable activity.
Monday, September 28, 2009
Thursday, September 24, 2009
AIDS Vaccine: Thailand tests yield positive results
For the first time a vaccine project is underway to reduce the risk of infection. The relative success of a test in Thailand has raised hopes on the possibility of an effective vaccine to fight the HIV virus in the future. In July this year, the first phase of testing from a South African vaccine research was also launched, marking the country’s second time to test an HIV vaccine. The Thai test results, according to experts, augur well for the South African trials.
"These new findings represent an important step forward in HIV vaccine research," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, which provided major funding and other support for the study. "For the first time, an investigational HIV vaccine has demonstrated some ability to prevent HIV infection among vaccinated individuals. Additional research is needed to better understand how this vaccine regimen reduced the risk of HIV infection, but certainly this is an encouraging advance for the HIV vaccine field.
"We thank the trial staff in Thailand and the United States for their years of effort in successfully conducting this study and the study participants and the people of Thailand for their long-standing support of HIV vaccine research," Dr. Fauci adds.
The Thai Phase III HIV vaccine study, also known as RV144, opened in October 2003. The placebo-controlled trial tested the safety and effectiveness of a prime-boost regimen of two vaccines: ALVAC-HIV vaccine (the primer dose), a modified canarypox vaccine developed by Sanofi Pasteur, based in Lyon, France, and AIDSVAX B/E vaccine (the booster dose), a glycoprotein 120 vaccine developed by Vaxgen Inc., and now licensed to Global Solutions for Infectious Diseases (GSID), based in South San Francisco, Calif. The vaccines are based on the subtype B and E HIV strains that commonly circulate in Thailand. The subtype B HIV strain is the one most commonly found in the United States.
Led by principal investigator Supachai Rerks-Ngarm, M.D., of the Thai Ministry of Public Health's Department of Disease Control, the study was sponsored by the U.S. Army in collaboration with NIAID, Sanofi Pasteur and GSID. The trial, conducted in the Rayong and Chon Buri provinces of Thailand, enrolled 16,402 men and women ages 18 to 30 years old at various levels of risk for HIV infection. Study participants received the ALVAC HIV vaccine or placebo at enrollment and again after 1 month, 3 months, and 6 months. The AIDSVAX B/E vaccine or placebo was given to participants at 3 and 6 months. Participants were tested for HIV infection every 6 months for 3 years. During each clinic visit, they were counseled on how to avoid becoming infected with HIV.
In the final analysis, 74 of 8,198 placebo recipients became infected with HIV compared with 51 of 8,197 participants who received the vaccine regimen. This level of effectiveness in preventing HIV infection was found to be statistically significant. The vaccine regimen had no effect, however, on the amount of virus in the blood of volunteers who acquired HIV infection during the study.
"The Thai study demonstrates why the HIV vaccine field must take a balanced approach to conducting both the basic research needed to discover and design new HIV vaccines and, when appropriate, testing candidate vaccines in people," says Margaret I. Johnston, Ph.D., director of NIAID's Vaccine Research Program within the Division of AIDS. "Both avenues provide critical information that will continue to help us better understand what is needed to develop a fully protective HIV vaccine."
NIAID and the collaborating partners are working with other scientific experts to determine next steps, including additional research of the RV144 vaccine regimen and the need to consider the impact of these new findings on other HIV vaccine candidates.
Individuals who acquired HIV infection while participating in the Thai trial have been provided access to HIV care and treatment, including highly active antiretroviral therapy based on the guidelines of the Thai Ministry of Public Health.
"These new findings represent an important step forward in HIV vaccine research," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, which provided major funding and other support for the study. "For the first time, an investigational HIV vaccine has demonstrated some ability to prevent HIV infection among vaccinated individuals. Additional research is needed to better understand how this vaccine regimen reduced the risk of HIV infection, but certainly this is an encouraging advance for the HIV vaccine field.
"We thank the trial staff in Thailand and the United States for their years of effort in successfully conducting this study and the study participants and the people of Thailand for their long-standing support of HIV vaccine research," Dr. Fauci adds.
The Thai Phase III HIV vaccine study, also known as RV144, opened in October 2003. The placebo-controlled trial tested the safety and effectiveness of a prime-boost regimen of two vaccines: ALVAC-HIV vaccine (the primer dose), a modified canarypox vaccine developed by Sanofi Pasteur, based in Lyon, France, and AIDSVAX B/E vaccine (the booster dose), a glycoprotein 120 vaccine developed by Vaxgen Inc., and now licensed to Global Solutions for Infectious Diseases (GSID), based in South San Francisco, Calif. The vaccines are based on the subtype B and E HIV strains that commonly circulate in Thailand. The subtype B HIV strain is the one most commonly found in the United States.
Led by principal investigator Supachai Rerks-Ngarm, M.D., of the Thai Ministry of Public Health's Department of Disease Control, the study was sponsored by the U.S. Army in collaboration with NIAID, Sanofi Pasteur and GSID. The trial, conducted in the Rayong and Chon Buri provinces of Thailand, enrolled 16,402 men and women ages 18 to 30 years old at various levels of risk for HIV infection. Study participants received the ALVAC HIV vaccine or placebo at enrollment and again after 1 month, 3 months, and 6 months. The AIDSVAX B/E vaccine or placebo was given to participants at 3 and 6 months. Participants were tested for HIV infection every 6 months for 3 years. During each clinic visit, they were counseled on how to avoid becoming infected with HIV.
In the final analysis, 74 of 8,198 placebo recipients became infected with HIV compared with 51 of 8,197 participants who received the vaccine regimen. This level of effectiveness in preventing HIV infection was found to be statistically significant. The vaccine regimen had no effect, however, on the amount of virus in the blood of volunteers who acquired HIV infection during the study.
"The Thai study demonstrates why the HIV vaccine field must take a balanced approach to conducting both the basic research needed to discover and design new HIV vaccines and, when appropriate, testing candidate vaccines in people," says Margaret I. Johnston, Ph.D., director of NIAID's Vaccine Research Program within the Division of AIDS. "Both avenues provide critical information that will continue to help us better understand what is needed to develop a fully protective HIV vaccine."
NIAID and the collaborating partners are working with other scientific experts to determine next steps, including additional research of the RV144 vaccine regimen and the need to consider the impact of these new findings on other HIV vaccine candidates.
Individuals who acquired HIV infection while participating in the Thai trial have been provided access to HIV care and treatment, including highly active antiretroviral therapy based on the guidelines of the Thai Ministry of Public Health.
Wednesday, September 23, 2009
Purchasing drugs online
Purchasing drugs online is one of the most easiest and convenient way to buy drugs. People prefer the purchasing of drugs online because they get the medicines at very reasonable costs there. Online pharmacies provide the free shipping facility to the customers who buy the medicines in lot. You get the door drop facility by the online pharmacies that make them a best option to purchase the medicines. Also, you get the customer support (24 X 7) that helps you to resolve any doubts you have regarding the online pharmacy.
Every one of us today buys the drugs online. But, recently a case of fake drugs to be sold by some online pharmacy was reported. So, it is my request to all readers that please confirm before buying the drugs whether the online pharmacy is authentic & genuine. The best way is to check whether the medicines sold by the online pharmacy are at least approved by the world health organization. This is must necessity that every customer should confirm. Always make it a point to confirm that active constituent of the drugs are approved by the FDA then only buy drugs online.
Online pharmacy has become the favorite choice of the customers. But, some people have started taking the wrong advantage of this and thus they have started using internet in wrong way. Many online pharmacies are even cheating their customers. So, the better option for such a thing would be to confirm before buying the medicines that online pharmacy is the approved drug supplier and don’t have any criminal cases running against it. Customers should never purchase lot of medicines during the first purchase; this will protect you if the online pharmacy is fake.
The best way to confirm about the online pharmacy is to contact some of its old customers or gather the information about it from the internet. If you are doubt then contact the customer support of the particular pharmacy and make the things clear. One thing you must remember is that if you don’t get the medicines then you always have an option of chargeback available with us that will surely get back you the invested money.
Online pharmacy is the most suitable option to buy the drugs related to the sexual health drugs because we generally feel embarrassed to buy these medicines from the local vendor. But, remember that it is due to our embarrassment that we fail to confirm many things and get fallen into the trap of these fake online pharmacies. You can best do this by checking every detail of online pharmacy and once you are confirmed with all the things then we can surely move on to make the purchase. So, buy drugs online only from the authentic pharmacy.
Every one of us today buys the drugs online. But, recently a case of fake drugs to be sold by some online pharmacy was reported. So, it is my request to all readers that please confirm before buying the drugs whether the online pharmacy is authentic & genuine. The best way is to check whether the medicines sold by the online pharmacy are at least approved by the world health organization. This is must necessity that every customer should confirm. Always make it a point to confirm that active constituent of the drugs are approved by the FDA then only buy drugs online.
Online pharmacy has become the favorite choice of the customers. But, some people have started taking the wrong advantage of this and thus they have started using internet in wrong way. Many online pharmacies are even cheating their customers. So, the better option for such a thing would be to confirm before buying the medicines that online pharmacy is the approved drug supplier and don’t have any criminal cases running against it. Customers should never purchase lot of medicines during the first purchase; this will protect you if the online pharmacy is fake.
The best way to confirm about the online pharmacy is to contact some of its old customers or gather the information about it from the internet. If you are doubt then contact the customer support of the particular pharmacy and make the things clear. One thing you must remember is that if you don’t get the medicines then you always have an option of chargeback available with us that will surely get back you the invested money.
Online pharmacy is the most suitable option to buy the drugs related to the sexual health drugs because we generally feel embarrassed to buy these medicines from the local vendor. But, remember that it is due to our embarrassment that we fail to confirm many things and get fallen into the trap of these fake online pharmacies. You can best do this by checking every detail of online pharmacy and once you are confirmed with all the things then we can surely move on to make the purchase. So, buy drugs online only from the authentic pharmacy.
Subscribe to:
Posts (Atom)
